首页> 外文期刊>Open Veterinary Journal >The effect of renal diet in association with enalapril or benazepril on proteinuria in dogs with proteinuric chronic kidney disease
【24h】

The effect of renal diet in association with enalapril or benazepril on proteinuria in dogs with proteinuric chronic kidney disease

机译:肾饮食联合依那普利或贝那普利对蛋白尿性慢性肾脏病犬蛋白尿的影响

获取原文
       

摘要

Treating proteinuria in dogs reduces the progression of chronic kidney disease (CKD); renal diets and angiotensin -converting enzyme (ACE)-inhibitors are cornerstones of treatment. Whether different ACE-inhibitors have distinct?kidney protective effects is unknown; it is therefore hypothesized that renal diets and enalapril or benazepril have?different beneficial effects in proteinuric CKD dogs. Forty-four dogs with proteinuric CKD (IRIS stages 1-4) were?enrolled in the study and were fed renal diet for 30 days. Thereafter, they were randomly assigned to one of 2 groups.?Dogs in group A (n=22) received enalapril (0.5 mg/kg, q12h) and in group B (n=22) benazepril (0.5 mg/kg, q24h);?in both groups, dogs were fed the same renal diet. After randomization, dogs were monitored for 120 days. Body?weight and body condition score (BCS), serum concentrations of creatinine, blood urea nitrogen (BUN), albumin?and total proteins, and urine protein-to creatinine (UPC) ratio were compared at different time-points. After 30 days?of renal diet, creatinine, BUN and UPC ratio decreased significantly (p<0.0001). Compared to randomization, body?weight, BCS, albumin, total proteins, creatinine and BUN did not vary during follow-up in the 44 dogs and differences?between group A and B were not observed. However, the UPC ratio of group A at day 60, 90 and 150 was significantly?lower than in group B and compared to randomization (p<0.05). In group B it did not vary overtime. It is concluded?that the renal diet is beneficial to decrease creatinine, BUN and UPC ratio in proteinuric CKD dogs. Enalapril further?ameliorates proteinuria if administered along with renal diet.
机译:治疗犬蛋白尿症可减少慢性肾脏病(CKD)的进程;肾脏饮食和血管紧张素转换酶(ACE)抑制剂是治疗的基石。不同的ACE抑制剂是否具有独特的肾脏保护作用尚不清楚。因此,假设肾饮食和依那普利或贝那普利对蛋白尿性CKD犬有不同的有益作用。研究纳入了44只蛋白尿性CKD狗(IRIS 1-4期),并接受了肾脏饮食30天。此后,将它们随机分为2组。A组(n = 22)的狗接受依那普利(0.5 mg / kg,q12h),B组(n = 22)的苯那普利(0.5 mg / kg,q24h)在两组中,狗都接受相同的肾脏饮食。随机分组后,监测狗120天。在不同的时间点比较体重和身体状况评分(BCS),肌酐,血尿素氮(BUN),白蛋白和总蛋白的血清浓度以及尿蛋白与肌酐(UPC)的比率。肾脏饮食30天后,肌酐,BUN和UPC比值显着下降(p <0.0001)。与随机分组相比,在44只犬的随访期间,体重,BCS,白蛋白,总蛋白,肌酐和BUN没有变化,并且未观察到A组和B组之间的差异。然而,与随机分组相比,A组在第60、90和150天的UPC比率显着低于B组,且差异有统计学意义(p <0.05)。 B组中,加班时间没有变化。结论:肾脏饮食有利于降低蛋白尿性CKD犬的肌酐,BUN和UPC比。如果与肾脏饮食同时使用,依那普利可进一步改善蛋白尿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号